IQVIA HOLDINGS INC. Noncontrolling Interest, Increase from Business Combination
IQVIA HOLDINGS INC. (IQV) reported Noncontrolling Interest, Increase from Business Combination of $126.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Shareholders' Equity
us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination · last filed 2026-05-05
- IQVIA HOLDINGS INC. noncontrolling interest, increase from business combination for the quarter ending 2025-12-31 was $7.00M.
- IQVIA HOLDINGS INC. noncontrolling interest, increase from business combination for the quarter ending 2025-03-31 was $8.00M.
- IQVIA HOLDINGS INC. noncontrolling interest, increase from business combination for the quarter ending 2018-09-30 was $0.00.
- IQVIA HOLDINGS INC. noncontrolling interest, increase from business combination for the quarter ending 2018-06-30 was $10.00M.
- IQVIA HOLDINGS INC. noncontrolling interest, increase from business combination for fiscal 2025 was $126.00M.
- IQVIA HOLDINGS INC. noncontrolling interest, increase from business combination for fiscal 2016 was $1.00M.
- IQVIA HOLDINGS INC. noncontrolling interest, increase from business combination for fiscal 2012 was $580.00K, a 27.75% increase from fiscal 2011.
- IQVIA HOLDINGS INC. noncontrolling interest, increase from business combination for fiscal 2011 was $454.00K.
| Period end | Noncontrolling Interest, Increase from Business Combination 3 month | Noncontrolling Interest, Increase from Business Combination 6 month | Noncontrolling Interest, Increase from Business Combination 9 month | Noncontrolling Interest, Increase from Business Combination 12 month | Noncontrolling Interest, Increase from Business Combination 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $126.00M 10-K · filed 2026-02-17 | |||
| 2025-09-30 | $119.00M 10-Q · filed 2025-10-28 | ||||
| 2025-03-31 | $8.00M 10-Q · filed 2026-05-05 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-01 | $10.00M derived: sum of 2 quarters · filed 2019-11-01 | |||
| 2018-06-30 | $10.00M 10-Q · filed 2019-11-01 | ||||
| 2016-12-31 | $1.00M 10-K · filed 2019-02-19 | -$1.00M 10-K · filed 2017-02-16 | |||
| 2012-12-31 | $580.00K 10-K · filed 2015-02-12 | ||||
| 2011-12-31 | $454.00K 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |